{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:44:04Z","timestamp":1793040244747,"version":"4.5.0"},"reference-count":84,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Congenital fibrinogen disorders (CFDs) include afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, and hypodysfibrinogenemia. The fibrinogen levels, the clinical features, and the genotype define several sub-types, each with specific biological and clinical issues. The diagnosis of CFDs is based on the measurement of activity and antigen fibrinogen levels as well as on the genotype. While relatively easy in quantitative fibrinogen disorders, the diagnosis can be more challenging in qualitative fibrinogen disorders depending on the reagents and methods used, and the underlying fibrinogen variants. Overall, quantitative and qualitative fibrinogen defects lead to a decrease in clottability, and usually in a bleeding tendency. The severity of the bleeding phenotype is moreover related to the concentration of fibrinogen. Paradoxically, patients with CFDs are also at risk of thrombotic events. The impact of the causative mutation on the structure and the fibrinogen level is one of the determinants of the thrombotic profile. Given the major role of fibrinogen in pregnancy, women with CFDs are particularly at risk of obstetrical adverse outcomes. The study of the fibrin clot properties can help to define the impact of fibrinogen disorders on the fibrin network. The development of next generation sequencing now allows the identification of genetic modifiers able to influence the global hemostasis balance in CFDs. Their integration in the assessment of the patient risk on an individual scale is an important step toward precision medicine in patients with such a heterogeneous clinical course.<\/jats:p>","DOI":"10.1055\/s-0044-1788898","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T23:30:11Z","timestamp":1723851011000},"page":"103-110","source":"Crossref","is-referenced-by-count":13,"title":["Clinical, Laboratory, and Molecular Aspects of Congenital Fibrinogen Disorders"],"prefix":"10.1055","volume":"51","author":[{"given":"Alessandro","family":"Casini","sequence":"additional","affiliation":[{"name":"Division of Angiology and Hemostasis, University Hospitals of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe de","family":"Moerloose","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Neerman-Arbez","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0036-1571340","article-title":"Laboratory and genetic investigation of mutations accounting for congenital fibrinogen disorders","volume":"42","author":"M Neerman-Arbez","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"13","key":"ref2","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: diagnosis and treatment","volume":"125","author":"R Palla","year":"2015","journal-title":"Blood"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jth.12916","article-title":"Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management","volume":"13","author":"A Casini","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1055\/s-0041-1742170","article-title":"Mutations accounting for congenital fibrinogen disorders: an update","volume":"48","author":"M Richard","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"09","key":"ref5","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/jth.14216","article-title":"Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH","volume":"16","author":"A Casini","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0036-1571339","article-title":"Clinical features and management of congenital fibrinogen deficiencies","volume":"42","author":"A Casini","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"21","key":"ref7","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.2020010116","article-title":"How I treat dysfibrinogenemia","volume":"138","author":"A Casini","year":"2021","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.thromres.2019.07.014","article-title":"The use of prophylaxis in the treatment of rare bleeding disorders","volume":"196","author":"A Shapiro","year":"2020","journal-title":"Thromb Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"100793","DOI":"10.1016\/j.blre.2020.100793","article-title":"Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management","volume":"48","author":"A Casini","year":"2021","journal-title":"Blood Rev"},{"issue":"03","key":"ref10","first-page":"e36459","article-title":"A case report of congenital afibrinogenemia and literature review of management of post-circumcision bleeding","volume":"15","author":"I Khan","year":"2023","journal-title":"Cureus"},{"issue":"06","key":"ref11","first-page":"321","article-title":"Problem-solving in clinical practice: a baby who won't stop bleeding","volume":"103","author":"E Dyer","year":"2018","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"22","key":"ref12","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood.2020009472","article-title":"Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia","volume":"137","author":"A Casini","year":"2021","journal-title":"Blood"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/hae.14579","article-title":"Clinical, biological, and genetic features in an afibrinogenemia patient series in Algeria","volume":"28","author":"S Hadjali-Saichi","year":"2022","journal-title":"Haemophilia"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"103203","DOI":"10.1016\/j.transci.2021.103203","article-title":"Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders","volume":"60","author":"S Mohsenian","year":"2021","journal-title":"Transfus Apheresis Sci"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/jth.15652","article-title":"Treatment of patients with rare bleeding disorders in the Netherlands: real-life data from the RBiN study","volume":"20","author":"D PMSM Maas","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref16","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI98734","article-title":"A fibrin biofilm covers blood clots and protects from microbial invasion","volume":"128","author":"F L Macrae","year":"2018","journal-title":"J Clin Invest"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0041-1732467","article-title":"The role of fibrin(ogen) in wound healing and infection control","volume":"48","author":"K J Kearney","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.3324\/haematol.2018.203901","article-title":"Impaired factor XIII activation in patients with congenital afibrinogenemia","volume":"104","author":"F Bridey","year":"2019","journal-title":"Haematologica"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/hae.12337","article-title":"Bone cysts in patients with afibrinogenaemia: a literature review and two new cases","volume":"20","author":"M E van Meegeren","year":"2014","journal-title":"Haemophilia"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5152\/tpa.2014.1070","article-title":"Spontaneous splenic rupture in a patient with congenital afibrinogenemia","volume":"49","author":"B C Arcag\u00f6k","year":"2014","journal-title":"Turk Pediatri Ars"},{"issue":"07","key":"ref21","doi-asserted-by":"crossref","first-page":"106526","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106526","article-title":"Medical management of a mural thrombus inducing repeated ischemic strokes in a patient with congenital afibrinogenemia","volume":"31","author":"M Nishihori","year":"2022","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1111\/hae.14092","article-title":"Portal vein thrombosis in a patient known for congenital afibrinogenemia","volume":"26","author":"M Greenblatt","year":"2020","journal-title":"Haemophilia"},{"issue":"09","key":"ref23","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1055\/a-1745-0420","article-title":"Impact of fibrinogen infusion on thrombin generation and fibrin clot structure in patients with inherited afibrinogenemia","volume":"122","author":"C Khayat","year":"2022","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/ijms22020655","article-title":"Venous thrombosis and thrombocyte activity in zebrafish models of quantitative and qualitative fibrinogen disorders","volume":"22","author":"R J Fish","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"01","key":"ref25","first-page":"105","article-title":"Update on antithrombin I (fibrin)","volume":"98","author":"M W Mosesson","year":"2007","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF00252836","article-title":"Increased prothrombin activation in a patient with congenital afibrinogenemia is reversible by fibrinogen substitution","volume":"72","author":"W Korte","year":"1994","journal-title":"Clin Investig"},{"issue":"09","key":"ref27","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1538-7836.2011.04424.x","article-title":"Fibrinogen replacement therapy for congenital fibrinogen deficiency","volume":"9","author":"L Bornikova","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000452864","article-title":"Thrombosis in inherited fibrinogen disorders","volume":"44","author":"W Korte","year":"2017","journal-title":"Transfus Med Hemother"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1160\/TH14-06-0514","article-title":"Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data","volume":"113","author":"C Solomon","year":"2015","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/vox.12424","article-title":"Post-authorization safety study of Clottafact\u00ae, a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study","volume":"111","author":"C N\u00e9grier","year":"2016","journal-title":"Vox Sang"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1999.01681.x","article-title":"Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia","volume":"107","author":"M Lak","year":"1999","journal-title":"Br J Haematol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1076029620912819","DOI":"10.1177\/1076029620912819","article-title":"Women with congenital hypofibrinogenemia\/afibrinogenemia: from birth to death","volume":"26","author":"Y Zhang","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0042-1758117","article-title":"Planning pregnancy and birth in women with inherited bleeding disorders","volume":"49","author":"A K Malinowski","year":"2023","journal-title":"Semin Thromb Hemost"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/rth2.12300","article-title":"Pregnancy outcome in afibrinogenemia: Are we giving enough fibrinogen concentrate? A case series","volume":"4","author":"J L Saes","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1111\/hae.13415","article-title":"Successful delivery in an patient with afibrinogenemia after three abortions: a case report and review of the literature","volume":"24","author":"M Karimi","year":"2018","journal-title":"Haemophilia"},{"issue":"05","key":"ref36","first-page":"e478","article-title":"Three successful deliveries involving a woman with congenital afibrinogenaemia - conventional fibrinogen concentrate infusion vs. \u2018as required\u2019 fibrinogen concentrate infusion based on changes in fibrinogen clearance","volume":"22","author":"T Oda","year":"2016","journal-title":"Haemophilia"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/hae.12584","article-title":"Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis","volume":"21","author":"A Lebreton","year":"2015","journal-title":"Haemophilia"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3390\/ijms18122711","article-title":"Fibrinogen as a pleiotropic protein causing human diseases: the mutational burden of A\u03b1, B\u03b2, and \u03b3 chains","volume":"18","author":"E M Paraboschi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-7196-1_8","article-title":"Determination of fibrinogen and thrombin time (TT)","volume":"1646","author":"A Undas","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ijlh.14201","article-title":"International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders","volume":"46","author":"I Mackie","year":"2023","journal-title":"Int J Lab Hematol"},{"issue":"04","key":"ref41","first-page":"1028","article-title":"Use of fibrinogen determination methods in differential diagnosis of hypofibrinogenemia and dysfibrinogenemia","volume":"67","author":"I Skornova","year":"2021","journal-title":"Clin Lab"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.thromres.2018.12.018","article-title":"Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders","volume":"174","author":"A Suzuki","year":"2019","journal-title":"Thromb Res"},{"issue":"06","key":"ref43","first-page":"1392","article-title":"OC 75.3 phenotype and genotype characterization of patients with congenital fibrinogen deficiencies: a retrospective analysis of the PRO-RBDD database","volume":"8","author":"S Mohsenian","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"04","key":"ref44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"F Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"20","key":"ref45","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1182\/bloodadvances.2020002740","article-title":"Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study","volume":"4","author":"J L Saes","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/biomedicines8120605","article-title":"A novel nonsense mutation in FGB (c.1421G>A; p.Trp474Ter) in the beta chain of fibrinogen causing hypofibrinogenemia with bleeding phenotype","volume":"8","author":"T Simurda","year":"2020","journal-title":"Biomedicines"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.22551\/2023.39.1002.10253","article-title":"Concomitant hypofibrinogenemia and factor XI deficiency as rare cause of bleeding during urgent dentistry: case report and short review of the literature","volume":"10","author":"C Sucker","year":"2023","journal-title":"Arch Clin Cases"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/jcm11041083","article-title":"Heterogeneity of genotype-phenotype in congenital hypofibrinogenemia-a review of case reports associated with bleeding and thrombosis","volume":"11","author":"M Brunclikova","year":"2022","journal-title":"J Clin Med"},{"issue":"04","key":"ref49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/MBC.0000000000001125","article-title":"Thrombosis-associated hypofibrinogenemia: novel abnormal fibrinogen variant FGG c.8G>A with oxidative posttranslational modifications","volume":"33","author":"E Ceznerov\u00e1","year":"2022","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MBC.0000000000000790","article-title":"Recurrent superficial venous thrombophlebitis because of mutations in the protein C and fibrinogen genes in a young Argentinian female","volume":"30","author":"H A Guglielmone","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.3390\/ijms18122717","article-title":"Fibrinogen gamma chain mutations provoke fibrinogen and apolipoprotein B plasma deficiency and liver storage","volume":"18","author":"F Callea","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"14","key":"ref52","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.3390\/ijms21145139","article-title":"Structural characteristics in the \u03b3 chain variants associated with fibrinogen storage disease suggest the underlying pathogenic mechanism","volume":"21","author":"G Burcu","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"21","key":"ref53","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.3390\/ijms21217830","article-title":"Hereditary hypofibrinogenemia with hepatic storage","volume":"21","author":"R Asselta","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"08","key":"ref54","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.jtha.2023.04.035","article-title":"Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study","volume":"21","author":"J Hugon-Rodin","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/hae.14754","article-title":"Physiological correction of hereditary mild hypofibrinogenemia during pregnancy","volume":"29","author":"R Marchi","year":"2023","journal-title":"Haemophilia"},{"issue":"06","key":"ref56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/ijlh.12721","article-title":"Potential misdiagnosis of dysfibrinogenaemia: Data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories","volume":"39","author":"I Jennings","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"01","key":"ref57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ejh.13333","article-title":"Different sensitivity of von Clauss reagents for the diagnosis of dysfibrinogenemia","volume":"104","author":"M Vasse","year":"2020","journal-title":"Eur J Haematol"},{"issue":"05","key":"ref58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MBC.0000000000001237","article-title":"Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen","volume":"34","author":"M J Marin","year":"2023","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"01","key":"ref59","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1055\/s-0041-1740644","article-title":"Fibrinogen Longmont: A clinically heterogeneous dysfibrinogenemia with discrepant fibrinogen results influenced by clot detection method and reagent","volume":"6","author":"B Leung","year":"2022","journal-title":"TH Open"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.thromres.2022.07.005","article-title":"Congenital (hypo-)dysfibrinogenemia and bleeding: a systematic literature review","volume":"217","author":"Y Li","year":"2022","journal-title":"Thromb Res"},{"issue":"03","key":"ref61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2014-06-582866","article-title":"Natural history of patients with congenital dysfibrinogenemia","volume":"125","author":"A Casini","year":"2015","journal-title":"Blood"},{"issue":"04","key":"ref62","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bcmd.2015.06.002","article-title":"Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia","volume":"55","author":"J Zhou","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"102489","DOI":"10.1016\/j.bcmd.2020.102489","article-title":"Identification and characterization of novel mutations in Chinese patients with congenital fibrinogen disorders","volume":"86","author":"P Zhou","year":"2021","journal-title":"Blood Cells Mol Dis"},{"issue":"04","key":"ref64","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/rth2.12127","article-title":"Identification and characterization of novel mutations implicated in congenital fibrinogen disorders","volume":"2","author":"N Smith","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/ejh.13296","article-title":"Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders","volume":"103","author":"G Castaman","year":"2019","journal-title":"Eur J Haematol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.thromres.2019.08.012","article-title":"Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations","volume":"182","author":"E Wypasek","year":"2019","journal-title":"Thromb Res"},{"issue":"06","key":"ref67","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s12185-020-02842-9","article-title":"Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia","volume":"111","author":"T Simurda","year":"2020","journal-title":"Int J Hematol"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0038-1653741","article-title":"Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen","volume":"73","author":"F Haverkate","year":"1995","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref69","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V82.8.2462.2462","article-title":"Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure","volume":"82","author":"J P Collet","year":"1993","journal-title":"Blood"},{"issue":"01","key":"ref70","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0006-3495(96)79596-6","article-title":"Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots","volume":"70","author":"J P Collet","year":"1996","journal-title":"Biophys J"},{"issue":"02","key":"ref71","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/rth2.12183","article-title":"Fibrinogen \u03b1C domain: its importance in physiopathology","volume":"3","author":"J Soria","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"06","key":"ref72","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/a-2094-7191","article-title":"Fibrinogen Bonn (p. Arg510Cys) in the A\u03b1-chain is associated with high risk of venous thrombosis","volume":"43","author":"V Iva\u0161kevi\u010dius","year":"2023","journal-title":"Hamostaseologie"},{"issue":"12","key":"ref73","first-page":"934","article-title":"Fibrinogen \u0141\u00f3d\u017a: a new cause of dysfibrinogenemia associated with recurrent thromboembolic arterial events","volume":"129","author":"J Treli\u0144ski","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"bcr2017221375","DOI":"10.1136\/bcr-2017-221375","article-title":"Acute renal artery infarction secondary to dysfibrinogenemia","volume":"2017","author":"K Keinath","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"08","key":"ref75","doi-asserted-by":"crossref","first-page":"e12619","DOI":"10.1002\/rth2.12619","article-title":"Management of congenital dysfibrinogenemia in pregnancy: a challenging patient case","volume":"5","author":"M Langer","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"05","key":"ref76","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/hae.13825","article-title":"Obstetrical and postpartum complications in women with hereditary fibrinogen disorders: a systematic literature review","volume":"25","author":"V Valiton","year":"2019","journal-title":"Haemophilia"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.thromres.2018.10.018","article-title":"A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the \u03b3165Cys-B\u03b2227Cys disulfide bond and ultimately leads to hypofibrinogenemia","volume":"172","author":"W Zhou","year":"2018","journal-title":"Thromb Res"},{"issue":"05","key":"ref78","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/jth.13655","article-title":"Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation","volume":"15","author":"A Casini","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref79","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/bjh.19039","article-title":"Congenital fibrinogen disorders: Strengthening genotype-phenotype correlations through novel genetic diagnostic tools","volume":"203","author":"R Ramanan","year":"2023","journal-title":"Br J Haematol"},{"issue":"02","key":"ref80","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood-2007-05-091231","article-title":"Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity","volume":"111","author":"R Ajjan","year":"2008","journal-title":"Blood"},{"issue":"03","key":"ref81","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V96.3.1177","article-title":"alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism","volume":"96","author":"A M Carter","year":"2000","journal-title":"Blood"},{"issue":"02","key":"ref82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0041-1730358","article-title":"Dysfibrinogenemia-potential impact of genotype on thrombosis or bleeding","volume":"48","author":"M V Bor","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"ref83","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2012-09-306639","article-title":"Mechanisms of fibrin polymerization and clinical implications","volume":"121","author":"J W Weisel","year":"2013","journal-title":"Blood"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2020.11.003","article-title":"Fibrin clot properties to assess the bleeding phenotype in unrelated patients with hypodysfibrinogenemia due to novel fibrinogen mutations","volume":"197","author":"R Marchi","year":"2021","journal-title":"Thromb Res"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1788898.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:41:08Z","timestamp":1740008468000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1788898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":84,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,2,19]]},"published-print":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1788898","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]}}}